CNMD FY 2019 Earnings Report — CONMED Corporation Revenue & Financial Results | Market Cap Arena

CONMED CorporationCNMD

FY 2019 Earnings

Reported February 24, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2019	Prior Q	FY 2018	QoQ Change	YoY Change
Revenue	$955M	—	$860M	—	11.1%
Op. Income	$79M	—	$71M	—	11.0%
Gross Margin	54.9%	—	54.6%	—	0.4pp
Net Margin	3.0%	—	4.8%	—	-1.8pp
EPS (Diluted)	$0.97	—	$1.41	—	-31.2%
Free Cash Flow	$75M	—	$58M	—	29.0%

Revenue Flow

Item	Amount
REVENUE	$955M
Cost of Revenue	$430M
GROSS PROFIT	$525M
R&D Expenses	$45M
Selling & Marketing	$0
General & Administrative	$400M
SG&A Expenses	$400M
Other Expenses	$0
Operating Expenses	$446M
Cost & Expenses	$876M
OPERATING INCOME	$79M
Interest Income	$0
Interest Expense	$43M
Other Income/Expenses	-$48M
INCOME BEFORE TAX	$31M
Income Tax Expense	$3M
Net Income from Continuing Ops	$29M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$29M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$29M
D&A	$72M
EBIT	$74M
EBITDA	$146M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$955M
Cost of Revenue	$430M
GROSS PROFIT	$525M
R&D Expenses	$45M
Selling & Marketing	$0
General & Administrative	$400M
SG&A Expenses	$400M
Other Expenses	$0
Operating Expenses	$446M
Cost & Expenses	$876M
OPERATING INCOME	$79M
Interest Income	$0
Interest Expense	$43M
Other Income/Expenses	-$48M
INCOME BEFORE TAX	$31M
Income Tax Expense	$3M
Net Income from Continuing Ops	$29M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$29M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$29M
D&A	$72M
EBIT	$74M
EBITDA	$146M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$29M
Depreciation & Amortization	$72M
Stock-Based Compensation	$12M
Deferred Income Tax	-$6M
Other Non-Cash Items	$12M
Change in Working Capital	-$24M
OPERATING CASH FLOW	$95M
Capital Expenditure	-$20M
Acquisitions (Net)	-$368M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$0
NET CASH FROM INVESTING	-$388M
Net Debt Issuance	$363M
Common Stock Repurchased	-$31M
Common Dividends Paid	-$23M
Other Financing Activities	-$39M
NET CASH FROM FINANCING	$301M
FREE CASH FLOW	$75M
Net Change in Cash	$8M

Balance Sheet

Item	Amount
Cash & Equivalents	$26M
Short-Term Investments	$0
Net Receivables	$189M
Inventory	$165M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$397M
PP&E (Net)	$119M
Goodwill	$618M
Intangible Assets	$533M
Long-Term Investments	$0
Tax Assets	$6M
Other Non-Current Assets	$102M
TOTAL NON-CURRENT ASSETS	$1.4B
TOTAL ASSETS	$1.8B
Account Payables	$56M
Short-Term Debt	$13M
Deferred Revenue	$0
Other Current Liabilities	$111M
TOTAL CURRENT LIABILITIES	$188M
Long-Term Debt	$755M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$74M
Other Non-Current Liabilities	$30M
TOTAL NON-CURRENT LIABILITIES	$877M
TOTAL LIABILITIES	$1.1B
Common Stock	$313.0K
Additional Paid-In Capital	$379M
Retained Earnings	$471M
Treasury Stock	-$81M
Accum. Other Comp. Income	-$59M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$710M
Minority Interest	$0
TOTAL EQUITY	$710M
TOTAL LIABILITIES & EQUITY	$1.8B
Total Debt	$793M
Net Debt	$767M